Home/Filings/4/0001266375-07-000074
4//SEC Filing

Kremer Alton B 4

Accession 0001266375-07-000074

CIK 0000835887other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 5:05 PM ET

Size

11.7 KB

Accession

0001266375-07-000074

Insider Transaction Report

Form 4
Period: 2007-10-01
Kremer Alton B
VP, Clinical Research
Transactions
  • Exercise/Conversion

    ESPP (right to buy)

    2007-10-012,3280 total
    Exercise: $19.03From: 2007-10-01Exp: 2007-10-02Common Stock (2,328 underlying)
  • Tax Payment

    Common Stock

    2007-10-01$22.39/sh2,119$47,44429,685 total
  • Award

    ESPP (right to buy)

    2007-10-01+735735 total
    Exercise: $22.11From: 2008-04-01Exp: 2008-04-01Common Stock (735 underlying)
  • Exercise/Conversion

    Common Stock

    2007-10-01$19.03/sh+2,328$44,30231,804 total
Footnotes (4)
  • [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
  • [F2]Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan.
  • [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
  • [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1
  • filerCIK 0001327416

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:05 PM ET
Size
11.7 KB